看空，垃圾股_老虎社区_美港股上老虎

看空，垃圾股

Nrx Pharmaceuticals, Inc.盘中异动早盘急速下跌5.03%报3.31美元

北京时间2025年01月24日00时11分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.03%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。

Nrx Pharmaceuticals, Inc.盘中异动早盘急速下跌5.03%报3.31美元

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":395832873607464,"tweetId":"395832873607464","gmtCreate":1737663803232,"gmtModify":1737667078385,"author":{"id":3549899692349084,"idStr":"3549899692349084","authorId":3549899692349084,"authorIdStr":"3549899692349084","name":"富銀國際","avatar":"https://static.tigerbbs.com/6e06e980991b0b71cc8ba0dbe94396eb","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":12,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>看空，垃圾股</p></body></html>","htmlText":"<html><head></head><body><p>看空，垃圾股</p></body></html>","text":"看空，垃圾股","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/395832873607464","repostId":2505459230,"repostType":2,"repost":{"id":"2505459230","kind":"news","pubTimestamp":1737648710,"share":"https://www.laohu8.com/m/news/2505459230?lang=&edition=full","pubTime":"2025-01-24 00:11","market":"us","language":"zh","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.03%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505459230","media":"市场透视","summary":"北京时间2025年01月24日00时11分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.03%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","content":"<html><body><article><p>北京时间2025年01月24日00时11分，Nrx Pharmaceuticals, Inc.（NRXP.us）股票出现异动，股价急速跳水5.03%。截至发稿，该股报3.31美元/股，成交量9.9721万股，<span>换手率</span>0.82%，振幅6.03%。</p><p>最近的财报数据显示，该股实现<span>营业收入</span>0.00美元，<span>净利润</span>-1.62百万美元，<span>每股收益</span>-0.15美元，<span>毛利</span>-2000.00美元，市盈率-1.58倍。</p><p>机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。</p><p>Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Dogwood <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, Inc.、Nutriband Inc C/Wts (To Pur Com)、<a href=\"https://laohu8.com/S/XCUR\">Exicure, Inc.</a>涨幅较大，<a href=\"https://laohu8.com/S/HEPA\">Hepion Pharmaceuticals, Inc.</a>、Dogwood Therapeutics, Inc.、<a href=\"https://laohu8.com/S/QNRX\">Quoin Pharmaceuticals</a> Ltd较为活跃，换手率分别为3521.80%、1441.64%、648.18%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts (To Pur Com)、<a href=\"https://laohu8.com/S/JUNS\">Jupiter Neurosciences</a>, Inc.，振幅分别为186.07%、64.29%、55.57%。</p><p>Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。 该公司宣布了新型冠状病毒感染症(covid - 19病毒)呼吸衰竭治疗剂ZYESAMI (Aviptadil)的商业化。该公司还在开发NRX-100/101，这是首个用于治疗双相抑郁症患者急性自杀意念和行为的序贯药物方案。</p><p>（以上内容为<a href=\"https://laohu8.com/S/00700\">腾讯</a>自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nrx Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.03%报3.31美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNrx Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.03%报3.31美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-24 00:11 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001150960e5847&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年01月24日00时11分，Nrx Pharmaceuticals, Inc.（NRXP.us）股票出现异动，股价急速跳水5.03%。截至发稿，该股报3.31美元/股，成交量9.9721万股，换手率0.82%，振幅6.03%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.62百万美元，每股收益-0.15美元，毛利-2000.00美元，市盈率-1.58倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001150960e5847&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","NRXP":"NRX Pharmaceuticals Inc."},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001150960e5847&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2505459230","content_text":"北京时间2025年01月24日00时11分，Nrx Pharmaceuticals, Inc.（NRXP.us）股票出现异动，股价急速跳水5.03%。截至发稿，该股报3.31美元/股，成交量9.9721万股，换手率0.82%，振幅6.03%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.62百万美元，每股收益-0.15美元，毛利-2000.00美元，市盈率-1.58倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts (To Pur Com)、Exicure, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3521.80%、1441.64%、648.18%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts (To Pur Com)、Jupiter Neurosciences, Inc.，振幅分别为186.07%、64.29%、55.57%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。 该公司宣布了新型冠状病毒感染症(covid - 19病毒)呼吸衰竭治疗剂ZYESAMI (Aviptadil)的商业化。该公司还在开发NRX-100/101，这是首个用于治疗双相抑郁症患者急性自杀意念和行为的序贯药物方案。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","news_type":1},"isVote":1,"tweetType":1,"viewCount":281,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":11,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Nrx Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.03%报3.31美元

评论

热议股票

Nrx Pharmaceuticals, Inc.盘中异动早盘急速下跌5.03%报3.31美元